use of glp 1 in type 1 diabetes glp-1_analogs [TUSOM Glucagon-Like Peptide-1 Based Therapies: A

Trulicity (dulaglutide): This once-weekly subcutaneous injection (under the skin) is used to treat type 2 diabetes

Overview New York, NY Nov 27, 2025 Global GLP-1 Receptor Agonist Market size is expected to be worth around US$ 268.4 billion by 2034 from US$ 53.5 billion in 2024, growing at a CAGR of 17.5% during the forecast period 2025 to 2034

Do not use liraglutide injection if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Damage to the retina caused by diabetes

Subcutaneous ipamorelin injection delivers 8095% bioavailability, meaning nearly all administered peptide reaches growth hormone secretagogue receptors (GHS-R1a) in the pituitary gland

Clinical trials have also shown that its possibly beneficial for managing Parkinsons symptoms